Cross-source evidence timeline
Survodutide research timeline
Follow 11 selected, directly cited source records from June 25, 2025 through August 11, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Clinical trials
ClinicalTrials.gov record NCT06077864↗
PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-08-13T05:52:27.018Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was survodutide.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT07754461↗
PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT06632444↗
PeptideScanner retained ClinicalTrials.gov record NCT06632444 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.↗
Added to PeptideScanner August 13, 2026Clinical trials
ClinicalTrials.gov record NCT06632457↗
PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-08-13T05:52:27.009Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.↗
Added to PeptideScanner August 13, 2026Clinical trials
Survodutide liver-activity study record updated↗
ClinicalTrials.gov lists an active, not recruiting Survodutide study sponsored by Boehringer Ingelheim.↗
Added to PeptideScanner July 22, 2026Clinical trials
ClinicalTrials.gov record NCT07413913↗
PeptideScanner retained ClinicalTrials.gov record NCT07413913 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was survodutide.↗
Added to PeptideScanner September 9, 2026Clinical trials
ClinicalTrials.gov record NCT06176365↗
PeptideScanner retained ClinicalTrials.gov record NCT06176365 at 2026-07-30T16:20:49.317Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.↗
Added to PeptideScanner August 8, 2026Clinical trials
ClinicalTrials.gov record NCT06309992↗
PeptideScanner retained ClinicalTrials.gov record NCT06309992 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.↗
Added to PeptideScanner August 8, 2026Literature metadata
PubMed record PMID 41388343↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41388343 at 2026-07-30T16:25:14.127Z. PubMed recorded a metadata revision date of 2026-02-14 and an Entrez history date of 2025-12-13. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 41424209↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41424209 at 2026-07-30T16:25:14.150Z. PubMed recorded a metadata revision date of 2026-02-10 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026
Source year
2025
Literature metadata
PubMed record PMID 40557206↗
PeptideScanner retained PubMed bibliographic metadata for PMID 40557206 at 2026-07-30T18:26:54.791Z. PubMed recorded a metadata revision date of 2025-06-25 and an Entrez history date of 2025-06-25. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026